Serge Saxonov, Chief Executive Officer and Director of 10x Genomics, Inc. (NASDAQ:TXG), filed a statement of changes in beneficial ownership on August 24, 2026, reporting a disposition of Class A Common Stock dated August 20, 2026.

Key Highlights

  • Reporting person: Serge Saxonov, Chief Executive Officer and Director of 10x Genomics, Inc.
  • Transaction: 4,000 shares of Class A Common Stock disposed of (transaction code G) on August 20, 2026, at a price of $0.
  • Direct holdings after transaction: 1,104,380 shares of Class A Common Stock held directly.
  • Indirect holdings: 27 shares via the Andromeda Trust, 213,250 shares via the Y/S Descendants' Trust, and 71,644 shares via the Y/S Pot Trust, in each case with Saxonov serving as trustee.
  • Filing signed: Randy Wu, as Attorney-in-Fact for Serge Saxonov, on August 24, 2026.

Saxonov's Reported Disposition and Beneficial Ownership at 10x Genomics

According to the filing, Saxonov disposed of 4,000 shares of Class A Common Stock on August 20, 2026, using transaction code G, at a reported price of $0. Transaction code G designates a gift under SEC reporting conventions. Following this transaction, the filing reports that Saxonov directly holds 1,104,380 shares of Class A Common Stock in 10x Genomics, a company that develops genomics analysis instruments and related technologies used in biological research.

In addition to direct holdings, the filing discloses three pools of indirectly held shares. The Andromeda Trust holds 27 shares, the Y/S Descendants' Trust holds 213,250 shares, and the Y/S Pot Trust holds 71,644 shares. The filing states that Saxonov serves as trustee for each of these trusts. No derivative securities transactions were reported in Table II of the filing. The filing was submitted by one reporting person, and no amendment date was indicated, suggesting this is an original filing.

What Was Disclosed

The filing disclosed a gift of 4,000 Class A Common Stock shares by 10x Genomics CEO Serge Saxonov on August 20, 2026, at $0, with resulting direct beneficial ownership of 1,104,380 shares and additional indirect holdings across three trusts for which Saxonov serves as trustee.